United States
US 12,697,308 B2
Thermostable lipid nanoparticle and methods of use thereof
US 12,697,308 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Merck Sharp & Dohme LLC. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Merck Sharp & Dohme LLC
- Inventors
- Andrew Bett; Izzat T. Raheem; Jason W. Skudlarek
- Publication date
- 2026-08-04
- Filing date
- 2022-08-17
- Document type
- B2 Granted patent
- Also written as
- US 12,697,308 B2 · US12697308 · 12697308
Abstract
The present disclosure provides, among other things, a lipid nanoparticle adjuvant composition. The present disclosure provides pharmaceutical compositions that include a stable lipid nanoparticle adjuvant and human papillomavirus (HPV) virus-like particles (VLPs) of at least one type of human papillomavirus (HPV) selected from the group consisting of HPV types: 6, 11, 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 55, 56, 58, 59, 66, 68, 73, and 82.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free